Genentech, Inc’s publication on NPJ Precision Oncology.
SMC announced that Genentech, Inc. has published the results of a study using STAM™ model on NPJ Precision Oncology.
Title: “Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology”
Read more….https://www.ncbi.nlm.nih.gov/pubmed/30456308